Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Internal Validation of Circulating Tumor DNA (ctDNA) Sequencing in Muscle-Invasive Bladder Cancer and Upper Tract Urothelial Carcinoma: A Prospective Observational Study

NCT07756437 is registered in ClinicalTrials.gov with AZ Sint-Lucas Gent as lead sponsor.

NCT NCT07756437
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07756437 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Internal Validation of Circulating Tumor DNA (ctDNA) Sequencing in Muscle-Invasive Bladder Cancer and Upper Tract Urothelial Carcinoma: A Prospective Observational Study
Lead sponsor
AZ Sint-Lucas Gent
Phase
Observational
Overall status
Recruiting
Start date
November 7, 2025
Completion date
June 1, 2029
Enrollment
70 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

muscle-invasive bladder cancer (mibc), upper tract urothelial carcinoma, urothelial carcinoma (uc)